The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Chard Daniel R since 2015.
This trader's CIK number is 1289557.
At the time of last reporting, Chard Daniel R was the Chairman & CEO of Medifast Inc. (stock ticker symbol MED).
Also see all insider trading activities at Medifast Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | NUS | 0 | $0 | 17,500 | $816,725 | 45,000 | $837,300 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | MED | 381 | $5,002 | 0 | $0 | 0 | $0 |
2022 | MED | 1,121 | $207,596 | 0 | $0 | 24,072 | $0 |
2021 | MED | 0 | $0 | 19,885 | $5,434,477 | 0 | $0 |
2019 | MED | 0 | $0 | 0 | $0 | 210,000 | $0 |
2018 | MED | 975 | $149,448 | 0 | $0 | 0 | $0 |
1. Nu Skin Enterprises, Inc. (NUS)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-07-06 | NUS | Option Ex | 17,500 | 17.03 | 298,025 |
2015-07-06 | NUS | Sale | 17,500 | 46.67 | 816,725 |
2015-02-28 | NUS | Option Ex | 27,500 | 19.61 | 539,275 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-06-13 | MED | Buy | 381 | 13.13 | 5,002 |
2022-05-05 | MED | Buy | 431 | 183.25 | 78,980 |
2022-02-04 | MED | Buy | 690 | 186.40 | 128,616 |
2021-12-31 | MED | Option Ex | 24,072 | .00 | 0 |
2021-06-17 | MED | Sale | 6,365 | 264.62 | 1,684,325 |
2021-06-15 | MED | Sale | 7,696 | 279.40 | 2,150,300 |
2021-06-16 | MED | Sale | 5,824 | 274.70 | 1,599,852 |
2019-12-31 | MED | Option Ex | 210,000 | .00 | 0 |
2018-11-08 | MED | Buy | 975 | 153.28 | 149,448 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chard Daniel R (Chairman & CEO of Medifast Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.